As part of its advocacy program in the United States, ACRO submits comments to U.S. legislators. This comment letter, submitted by ACRO to Rep. Jake Auchincloss (D-MA-04) in 2026 on his Next-Generation U.S. Clinical Development to Accelerate Cures discussion draft, can be found below.